For patients with stage III or IV Hodgkin lymphoma, nivolumab with doxorubicin, vinblastine, and dacarbazine (N+AVD) yields ...

The Reactor Assessment Tool allows the IAEA to explain the status of nuclear facilities, like power reactors, using simple language and color-coded diagrams. It receives safety data from IAEA ...

A combined analysis of data over years in patients in Phase 2 trials of supports benefits for those up to age 65 and moderate ...

Results from a phase 3 clinical trial show promise for a new standard of care for treating people with advanced cervical ...

Patients with a head and neck cancer subtype did not show differences in survival outcomes when treated with radiation versus ...

Jazz Pharmaceuticals contends that its alkylating agent Zepzelca significantly improved both overall survival and progression ...

For a subset of patients with inoperable or metastatic HR-positive/HER2-negative breast cancer, treatment with datopotamab ...

Jazz Pharmaceuticals released Phase 3 trial results for Zepzelca in combination with Roche's atezolizumab as a maintenance ...

Therapeutics announces new survival data, outperforming patients, and survival rates in its Phase 2 metastatic breast cancer ...

Researchers investigated whether induction chemotherapy improves PFS and OS in patients with locally advanced cervical cancer ...

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can directly cause disease progression and metastasis, leading ...

BriaCell patients1 remained alive one year since enrollment in BriaCell’s Phase 2 study, markedly exceeding the survival rate of current ...